Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. VI. Polyoma virus infection
✍ Scribed by Ion Gresser; Chantal Maury; Chantal Kress; Daniel Blangy; Marie-Thérèse Maunoury
- Publisher
- John Wiley and Sons
- Year
- 1979
- Tongue
- French
- Weight
- 712 KB
- Volume
- 24
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
We have determined the effect of a single injection of potent sheep anti‐mouse interferon globulin on polyoma‐virus‐induced early runting disease and tumor formation in Swiss mice. When newborn mice were injected with ≥9 × 10^6^ PFU of polyoma virus, 16% (7/44) of mice runted and died in contrast to 96% (45/47) of mice injected with virus and anti‐interferon globulin. Likewise, a greater percentage of mice injected with lower doses of virus and anti‐interferon globulin developed tumors than did control virus‐injected mice. These results suggest that interferon is an important factor in determining the susceptibility of newborn mice to polyoma virus.
📜 SIMILAR VOLUMES
## Abstract We have determined the effect of sheep anti‐mouse interferon globulin on the anti‐tumor effects of poly I·C, statolon, tilorone, pyran copolymer and BCG in mice inoculated with Ehrlich ascites or L 1210 lymphoma cells. Whereas the anti‐tumor effects of poly I·C and statolon were nullifi
MIRE-PARDUE, K., SATTERWHITE, L. L., & GILULA, N. 8. (1987). Immunological analysis of homologous gap junction antigens in vertebrate and invertebrate or- ganisms. J . Cell Biol. (in press.) 1 0 WARNER, A. E., GUTHRIE, S. C., & GILULA, N. B. (1984). Antibodies to gapjunctional protein selectively di
## Abstract The prolonged administration of potent sheep anti‐mouse type‐1 interferon globulin (anti‐IF IgG) had a marked potentiating effect on Moloney sarcoma virus (MSV) infection in mice. The extent of resistance to the MSV‐induced disease was age‐related. In 4‐week‐old BALB/c mice, anti‐IF IgG
Serum IgM anti-HBc was determined in 135 chronic HBsAg carriers with various categories of histological activity on liver biopsy and hepatitis B serological profile. Thirty-three patients were treated with interferon-a to investigate the correlation between serum IgM anti-HBc with histological activ